QNZ (RMML-00120852)
Cat. No.: RMML-00120852
Category: Inhibitors & Activators
INQUIRY
1 mg
5 mg
QNZ is a quinazoline derivative that inhibits nuclear factor, as well as CXCL1-mediated pro-inflammatory increase in potassium currents in adult rat neurons. It does not inhibit kinases in a standard screen. Neuroprotective in a glutamate toxicity assay using YAC128 medium spiny neuron cultures. Blocks amyloid precursor protein release in human SH-SY5Y neuroblastoma cells caused by muscarinic receptor activation.
Product Features
| Purity | ≥ 98% |
|---|---|
| Cross Reactivity | Human, Mouse, Non-Human Primate, Other, Rat |
Compound Information
| Target Pathways | NF-κB |
|---|---|
| CAS Number | 545380-34-5 |
| Molecular Formula | C₂₂H₂₀N₄O |
Storage & Shipping
| Handling | Refer to SDS for further information. |
|---|
For research use only. Not for clinical use.
